Volcanic Rock Materials for Defluoridation of Water in Fixed-Bed Column Systems

Consumption of drinking water with a high concentration of fluoride (>1.5 mg/L) causes detrimental health problems and is a challenging issue in various regions around the globe. In this study, a continuous fixed-bed column adsorption system was employed for defluoridation of water using volcanic rocks, virgin pumice (VPum) and virgin scoria (VSco), as adsorbents. The XRD, SEM, FTIR, BET, XRF, ICP-OES, and pH Point of Zero Charges (pH_PZC) analysis were performed for both adsorbents to elucidate the adsorption mechanisms and the suitability for fluoride removal. The effects of particle size of adsorbents, solution pH, and flow rate on the adsorption performance of the column were assessed at room temperature, constant initial concentration, and bed depth. The maximum removal capacity of 110 mg/kg for VPum and 22 mg/kg for VSco were achieved at particle sizes of 0.075–0.425 mm and <0.075 mm, respectively, at a low solution pH (2.00) and flow rate (1.25 mL/min). The fluoride breakthrough occurred late and the treated water volume was higher at a low pH and flow rate for both adsorbents. The Thomas and Adams–Bohart models were utilized and fitted well with the experimental kinetic data and the entire breakthrough curves for both adsorbents. Overall, the results revealed that the developed column is effective in handling water containing excess fluoride. Additional testing of the adsorbents including regeneration options is, however, required to confirm that the defluoridation of groundwater employing volcanic rocks is a safe and sustainable method.     

Development and Evaluation of Chitosan Nanoparticles for Ocular Delivery of Tedizolid Phosphate

This study investigates the development of topically applied non-invasive chitosan-nanoparticles (CSNPs) for ocular delivery of tedizolid phosphate (TZP) for the treatment of MRSA-related ocular and orbital infections. An ionic-gelation method was used to prepare TZP-encapsulated CSNPs using tripolyphosphate-sodium (TPP) as cross-linker. Particle characterization was performed by the DLS technique (Zeta-Sizer), structural morphology was observed by SEM. The drug encapsulation and loading were determined by the indirect method. In-vitro release was conducted through dialysis bags in simulated tear fluid (pH 7) with 0.25% Tween-80. Physicochemical characterizations were performed for ocular suitability of CSNPS. An antimicrobial assay was conducted on different strains of Gram-positive bacteria. Eye-irritation from CSNPs was checked in rabbits. Transcorneal flux and apparent permeability of TZP from CSNPs was estimated through excised rabbit cornea. Ionic interaction between the anionic and cationic functional groups of TPP and CS, respectively, resulted in the formation of CSNPs at varying weight ratios of CS/TPP with magnetic stirring (700 rpm) for 4 h. The CS/TPP weight ratio of 3.11:1 with 10 mg of TZP resulted in optimal-sized CSNPs (129.13 nm) with high encapsulation (82%) and better drug loading (7%). Release profiles indicated 82% of the drug was released from the TZP aqueous suspension (TZP-AqS) within 1 h, while it took 12 h from F2 to release 78% of the drug. Sustained release of TZP from F2 was confirmed by applying different release kinetics models. Linearity in the profile (suggested by Higuchi’s model) indicated the sustained release property CSNPs. F2 has shown significantly increased (p < 0.05) antibacterial activity against some Gram-positive strains including one MRSA strain (SA-6538). F2 exhibited a 2.4-fold increased transcorneal flux and apparent permeation of TZP as compared to TZP-AqS, indicating the better corneal retention. No sign or symptoms of discomfort in the rabbits’ eyes were noted during the irritation test with F2 and blank CSNPs, indicating the non-irritant property of the TZP-CSNPs. Thus, the TZP-loaded CSNPs have strong potential for topical use in the treatment of ocular MRSA infections and related inflammatory conditions.     

Formulation of Quaternized Aminated Chitosan Nanoparticles for Efficient Encapsulation and Slow Release of Curcumin

An effective drug nanocarrier was developed on the basis of a quaternized aminated chitosan (Q-AmCs) derivative for the efficient encapsulation and slow release of the curcumin (Cur)-drug. A simple ionic gelation method was conducted to formulate Q-AmCs nanoparticles (NPs), using different ratios of sodium tripolyphosphate (TPP) as an ionic crosslinker. Various characterization tools were employed to investigate the structure, surface morphology, and thermal properties of the formulated nanoparticles. The formulated Q-AmCs NPs displayed a smaller particle size of 162 ± 9.10 nm, and higher surface positive charges, with a maximum potential of +48.3 mV, compared to native aminated chitosan (AmCs) NPs (231 ± 7.14 nm, +32.8 mV). The Cur-drug encapsulation efficiency was greatly improved and reached a maximum value of 94.4 ± 0.91%, compared to 75.0 ± 1.13% for AmCs NPs. Moreover, the in vitro Cur-release profile was investigated under the conditions of simulated gastric fluid [SGF; pH 1.2] and simulated colon fluid [SCF; pH 7.4]. For Q-AmCs NPs, the Cur-release rate was meaningfully decreased, and recorded a cumulative release value of 54.0% at pH 7.4, compared to 73.0% for AmCs NPs. The formulated nanoparticles exhibited acceptable biocompatibility and biodegradability. These findings emphasize that Q-AmCs NPs have an outstanding potential for the delivery and slow release of anticancer drugs.     

新型壳聚糖荧光纳米粒的制备及pH敏感性能研究

以合成的具有羧基官能团的萘酰亚胺类化合物为荧光团,通过酰氯化法活化其中的羧基,并选用生物相容性较好的水溶性高分子聚合物——羧甲基壳聚糖(CMCS)为基质材料,以化学键合的方式将荧光团引入到CMCS基体中,得到新型荧光材料萘酰亚胺修饰羧甲基壳聚糖CMCS3N.通过红外光谱、紫外光谱及透射电子显微镜对CMCS3N的结构和形...     

Novel Polyelectrolyte Carboxymethyl Konjac Glucomannan–Chitosan Nanoparticles for Drug Delivery

Summary: Carboxymethyl Konjac Glucomannan–Chitosan (CKGM‐CS) nanoparticles, which are well dispersed and stable in aqueous solution, were spontaneously prepared under very mild conditions by polyelectrolyte complexation. Investigations of the physicochemical properties of these nanoparticles were undertaken. This study showed that the nanoparticulate system driven by complex formation has potential as an advanced drug‐delivery system for water‐soluble drugs.

Preparation mechanism of CS–CKGM nanoparticles.     

壳聚糖-海藻酸盐纳米粒子的制备及其对BSA的载药与释放特性

带相反电荷的聚电解质在水溶液中能通过静电相互作用自组装形成壳聚糖-海藻酸盐纳米粒。利用动态光散射纳米粒度分析仪考察了钙离子及壳聚糖对粒子粒径的影响。结果表明：钙离子的存在可使粒子粒径从268．5nm降为203．4nm,但随着钙离子含量的继续升高,粒径迅速增大,当钙离子浓度大于0．45g／L时形成凝胶。壳聚糖含量的增加和蛋白的包裹均会使粒径增大。所制备的纳米粒对BSA具有较高的包栽能力,并有一定的缓释作用。当壳聚糖投料量增加时,可使BSA在pH=7．4的PBS中的释放减慢。     

Paclitaxel-Loaded Magnetic Nanoparticles Based on Biotinylated N-Palmitoyl Chitosan: Synthesis,Characterization and Preliminary In Vitro Studies

A considerable interest in cancer research is represented by the development of magnetic nanoparticles based on biofunctionalized polymers for controlled-release systems of hydrophobic chemotherapeutic drugs targeted only to the tumor sites, without affecting normal cells. The objective of the paper is to present the synthesis and in vitro evaluation of the nanocomposites that include a magnetic core able to direct the systems to the target, a polymeric surface shell that provides stabilization and multi-functionality, a chemotherapeutic agent, Paclitaxel (PTX), and a biotin tumor recognition layer. To our best knowledge, there are no studies concerning development of magnetic nanoparticles obtained by partial oxidation, based on biotinylated N-palmitoyl chitosan loaded with PTX. The structure, external morphology, size distribution, colloidal and magnetic properties analyses confirmed the formation of well-defined crystalline magnetite conjugates, with broad distribution, relatively high saturation magnetization and irregular shape. Even if the ability of the nanoparticles to release the drug in 72 h was demonstrated, further complex in vitro and in vivo studies will be performed in order to validate the magnetic nanoparticles as PTX delivery system.     

Characterization of Chitosan/Alginate Self-Assembled Nanoparticles as a Protein Carrier

The aim of this study was to evaluate the effect of the polymeric ratios on the characteristics of chitosan/alginate (ch/alg) self-assembled nanoparticles and their potential as protein delivery vehicle. The nanoparticles were prepared using proper mixing of polymers in presence or absence of bovine serum albumin (BSA) as a protein model. Three formulations of nanoparticles comprising ch/alg ratios of 2:1, 1:1, and 1:2 were prepared. Size, shape and zeta potential of the formulations were studied by scanning electron microscopy (SEM) and nanosizer instruments. FTIR, and differential scanning calorimetery (DSC) studies were performed to investigate polymer-polymer or polymer-protein interactions. Release profiles and entrapment efficiencies of the nanoparticles were determined by calorimetric technique using appropriate techniques. Entrapment efficiency was 70% for ch/alg ratio of 1:1, 65% for 1:2, and 60% for 2:1. The z-average size of the nanoparticles were 403, 205, and 318 nm for ch/alg ratios of 2:1, 1:1, and 1:2, respectively. Average zeta potentials were ?47, +15, ?25 mV for 2:1, 1:1, and 1:2 as well. Considering the favorable features required for protein delivery systems, ch/alg (1:1) due to its smallest size, highest loading, and most homogenous shape was regarded as the best ratio.     

Synthesis Optimization of Quaternized Chitosan and its Action as Reducing and Stabilizing Agent for Gold Nanoparticles

The optimal conditions for synthesizing quaternized chitosan (QCS) via microwave irradiation were explored. The microwave temperature, time, power, mole ratio between chitosan and 2,3-epoxypropyltrimethyl ammonium chloride (ETA), volume ratio between isopropanol and water, and pH value of the reaction system were studied to evaluate the effect on the degree of substitution (DS). The structure of QCS was characterized by means of FT-IR, NMR, XPS and XRD. TGA and DTG were used to measure its thermal stability. At last, QCS acted as a reducing and stabilizing agent to greenly synthesize gold nanoparticles without adding any other chemical reagent.     

Controlled Assembly of Au,Ag, and Pt Nanoparticles with Chitosan

Working on the chain gang : A simple method for the controlled assembly of metal nanoparticles (Au, Ag, and Pt) into 1D chains (see figure) has been developed based on the electrostatic interaction of negatively charged carboxylic groups on the citrate ions surrounding the NPs and the positively charged chitosan polymer.

     

Chitosan Encapsulated Meloxicam Nanoparticles for Sustained Drug Delivery Applications: Preparation,Characterization, and Pharmacokinetics in Wistar Rats

Meloxicam (MLX) is currently used in the therapeutic management of both acute and chronic inflammatory disorders such as pain, injuries, osteoarthritis, and rheumatoid arthritis in both humans and animals. Gastrointestinal toxicity and occasional renal toxicity were observed in patients taking it for a long-term period. Meloxicam’s late attainment of peak plasma concentration results in a slow onset of action. The goal of the current study was to prepare and characterize chitosan encapsulated meloxicam nanoparticles (CEMNPs) with high bioavailability and less gastro intestinal toxicity in order to prevent such issues. The size of the prepared CEMNPs was approximately 110–220 nm with a zetapotential of +39.9 mV and polydispersity index of 0.268, suggesting that they were uniformly dispersed nanoparticles. The FTIR and UV-Vis spectroscopy have confirmed the presence of MLX in the prepared CEMNPs. The pharmacokinetics have been studied with three groups of male Wistar rats receiving either of the treatments, viz., 4 mg·kg⁻¹ of MLX and 1 or 4 mg·kg⁻¹ of CEMNPs. Plasma samples were collected until 48 h post administration, and concentrations of MLX were quantified by using reverse (C₁₈) phase HPLC. Non-compartmental analysis was applied to determine pharmacokinetic variables. Upon oral administration, the maximum concentration (C_max) was reached in 4 h for CEMNPs and 6 h for MLX. The mean area under the plasma MLX concentration-time curve from ‘zero’ to infinity (AUC_0–∞), half-life (t_1/2β), and mean resident time (MRT) of 1 mg·kg⁻¹ of CEMNPs was 1.4-, 2-, and 1.8-fold greater than 4 mg·kg⁻¹ of MLX. The prepared CEMNPs demonstrated quicker absorption and prolonged release along with a significant improvement in the bioavailability of MLX, paving a prospective path for the development of drugs with enhanced bioavailability with less side effects.     

纳米金–壳聚糖修饰电极循环伏安法测定抗坏血酸

介绍纳米金–壳聚糖修饰电极的制备方法及其测定抗坏血酸的分析应用。采用电沉积方法,将氯金酸与壳聚糖的混合电解液直接共沉积,制备了壳聚糖–纳米金修饰玻碳电极的电化学传感器。利用循环伏安法研究了抗坏血酸浓度、p H值等对抗坏血酸在修饰电极上的电化学行为的影响。实验结果表明,修饰电极对抗坏血酸具有良好的电催化氧化作用,抗坏血酸浓度在5×10~(–5)~1×10~(–3) mol/L范围内线性良好,回归方程为I_p=0.433 8c+0.881 9,相关系数为0.998 71。该法可指导纳米金–壳聚糖修饰电极的制备及抗坏血酸含量的测定。     

Fabrication of PEGylated Chitosan Nanoparticles Containing Tenofovir Alafenamide: Synthesis and Characterization

Tenofovir alafenamide (TAF) is an antiretroviral (ARV) drug that is used for the management and prevention of human immunodeficiency virus (HIV). The clinical availability of ARV delivery systems that provide long-lasting protection against HIV transmission is lacking. There is a dire need to formulate nanocarrier systems that can help in revolutionizing the way to fight against HIV/AIDS. Here, we aimed to synthesize a polymer using chitosan and polyethylene glycol (PEG) by the PEGylation of chitosan at the hydroxyl group. After successful modification and confirmation by FTIR, XRD, and SEM, TAF-loaded PEGylated chitosan nanoparticles were prepared and analyzed for their particle size, zeta potential, morphology, crystallinity, chemical interactions, entrapment efficacy, drug loading, in vitro drug release, and release kinetic modeling. The fabricated nanoparticles were found to be in a nanosized range (219.6 nm), with ~90% entrapment efficacy, ~14% drug loading, and a spherical uniform distribution. The FTIR analysis confirmed the successful synthesis of PEGylated chitosan and nanoparticles. The in vitro analysis showed ~60% of the drug was released from the PEGylated polymeric reservoir system within 48 h at pH 7.4. The drug release kinetics were depicted by the Korsmeyer–Peppas release model with thermodynamically nonspontaneous drug release. Conclusively, PEGylated chitosan has the potential to deliver TAF from a nanocarrier system, and in the future, cytotoxicity and in vivo studies can be performed to further authenticate the synthesized polymer.     

Evaluation of Chitosan Derivatives Modified Mesoporous Silica Nanoparticles as Delivery Carrier

Chitosan is a non-toxic biological material, but chitosan is insoluble in water, which hinders the development and utilization of chitosan. Chitosan derivatives N-2-Hydroxypropyl trimethyl ammonium chloride (N-2-HACC) and carboxymethyl chitosan (CMCS) with good water solubility were synthesized by our laboratory. In this study, we synthesized mesoporous SiO₂ nanoparticles by the emulsion, and then the mesoporous SiO₂ nanoparticles were modified with γ-aminopropyltriethoxysilane to synthesize aminated mesoporous SiO₂ nanoparticles; CMCS and N-2-HACC was used to cross-link the aminated mesoporous SiO₂ nanoparticles to construct SiO₂@CMCS-N-2-HACC nanoparticles. Because the aminated mesoporous SiO₂ nanoparticles with positively charged can react with the mucous membranes, the virus enters the body mainly through mucous membranes, so Newcastle disease virus (NDV) was selected as the model drug to evaluate the performance of the SiO₂@CMCS-N-2-HACC nanoparticles. We prepared the SiO₂@CMCS-N-2-HACC nanoparticles loaded with inactivated NDV (NDV/SiO₂@CMCS-N-2-HACC). The SiO₂@CMCS-N-2-HACC nanoparticles as delivery carrier had high loading capacity, low cytotoxicity, good acid resistance and bile resistance and enteric solubility, and the structure of NDV protein encapsulated in the nano vaccine was not destroyed. In addition, the SiO₂@CMCS-N-2-HACC nanoparticles could sustain slowly released NDV. Therefore, the SiO₂@CMCS-N-2-HACC nanoparticles have the potential to be served as delivery vehicle for vaccine and/or drug.     

Preparation,Characterization and Antibacterial Property Analysis of Cellulose Nanocrystals (CNC) and Chitosan Nanoparticles Fine-Tuned Starch Film

To improve the mechanical and antibacterial properties of traditional starch-based film, herein, cellulose nanocrystals (CNCs) and chitosan nanoparticles (CS NPs) were introduced to potato starch (PS, film-forming matrix) for the preparation of nanocomposite film without incorporation of additional antibacterial agents. CNCs with varied concentrations were added to PS and CS NPs composite system to evaluate the optimal film performance. The results showed that tensile strength (TS) of nanocomposite film with 0, 0.01, 0.05, and 0.1% (w/w) CNCs incorporation were 41, 46, 47 and 41 MPa, respectively. The elongation at break (EAB) reached 12.5, 10.2, 7.1 and 13.3%, respectively. Due to the reinforcing effect of CNCs, surface morphology and structural properties of nanocomposite film were altered. TGA analysis confirmed the existence of hydrogen bondings and electrostatic attractions between components in the film-forming matrix. The prepared nanocomposite films showed good antibacterial properties against both E. coli and S. aureus. The nanocomposite film, consist of three most abundant biodegradable polymers, could potentially serve as antibacterial packaging films with strong mechanical properties for food and allied industries.     

Electrospun Hybrid Nanofibers Based on Chitosan or N‐Carboxyethylchitosan and Silver Nanoparticles

Hybrid nanofibers from chitosan or N‐carboxyethylchitosan (CECh) and silver nanoparticles (AgNPs) were prepared by electrospinning using HCOOH as a solvent. AgNPs were synthesized in situ in the spinning solution. HCOOH slowed down the cross‐linking of the polysaccharides with GA enabling the reactive electrospinning in the presence of poly(ethylene oxide) (PEO). EDX analyses showed that AgNPs are uniformly dispersed in the nanofibers. Since AgNPs hampered the cross‐linking of chitosan and CECh with GA in the hybrid fibers, the imparting of water insolubility to the fibers was achieved at a second stage using GA vapors. The surface of chitosan/PEO/AgNPs nanofibers was enriched in chitosan and 15 wt.‐% of the incorporated AgNPs were on the fiber surface as evidenced by XPS.

     

羧甲基壳聚糖磁性纳米粒子的合成及应用

通过合成油酸修饰的Fe3O4纳米粒子和羧甲基壳聚糖直接包埋油酸修饰的Fe3O4纳米粒子的两步合成法制备了羧甲基壳聚糖磁性纳米粒子。采用透射电子显微镜、傅里叶变换红外光谱、振动样品磁强计和同步热分析测试技术对制备的羧甲基壳聚糖磁性纳米粒子进行了表征。所得磁性纳米粒子呈规则球形,粒径约为10 nm;表面含羧基,且具有很好的顺磁性和稳定性。考察了羧甲基壳聚糖磁性纳米粒子对阿霉素的载药量和对阿霉素在磷酸盐缓冲溶液中的缓释性能。结果表明,磁性纳米粒子对阿霉素展示了较高的载药量(91.8 mg/g),结合了阿霉素的磁性复合物对阿霉素的缓释作用明显,说明制备的羧甲基壳聚糖磁性纳米粒子有望作为治疗肿瘤的纳米磁靶向药物输送载体。     

Oregano and Thyme Essential Oils Encapsulated in Chitosan Nanoparticles as Effective Antimicrobial Agents against Foodborne Pathogens

The use of natural compounds with biocidal activity to fight the growth of bacteria responsible for foodborne illness is one of the main research challenges in the food sector. This study reports the preparation and physicochemical characterization of chitosan nanoparticles loaded with Thymus capitatus (Th-CNPs) and Origanum vulgare (Or-CNPs) essential oils. The nanosystems were obtained by ionotropic gelation technique with high encapsulation efficiency (80–83%) and loading capacity (26–27%). Nanoparticles showed a spherical shape, bimodal particle size distribution, and good stability (zeta potential values > 40 mV). The treatment of the nanosuspensions at different temperatures (4 and 40 °C) and storage times (7, 15, 21, and 30 days) did not affect their physicochemical parameters and highlights their reservoir ability for essential oils also under stressful conditions. Both Or-CNPs and Th-CNPs exhibited an enhanced bactericidal activity against foodborne pathogens (S. aureus, E. coli, L. monocytogenes) than pure essential oils. These ecofriendly nanosystems could represent a valid alternative to synthetic preservatives and be of interest for health and food safety.     

New Nanocomposite Based on Prussian Blue Nanoparticles/Carbon Nanotubes/Chitosan and Its Application for Assembling of Amperometric Glucose Biosensor

Abstract

A new nanocomposite was developed by combination of prussian blue (PB) nanoparticles and multiwalled carbon nanotubes (MWNTs) in the matrix of biopolymer chitosan (CHIT). The PB and MWNTs had a synergistic electrocatalytic effect toward the reduction of hydrogen peroxide. The CHIT/MWNTs/PB nanocomposite‐modified glassy carbon (GC) electrode could amplify the reduction current of hydrogen peroxide by ～35 times compared with that of CHIT/MWNTs/GC electrode and reduce the response time from ～60 s for CHIT/PB/GC to 3 s. Besides, the CHIT/MWNTs/PB nanocomposite‐modified GC electrode could reduce hydrogen peroxide at a much lower applied potential and inhibit the responses of interferents such as ascorbic acid (AA) uric acid (UA) and acetaminophen (AC). With glucose oxidase (GOx) as an enzyme model, a new glucose biosensor was fabricated. The biosensor exhibited excellent sensitivity (the detection limit is down to 2.5 µM), fast response time (less than 5 s), wide linear range (from 4 µM to 2 mM), and good selection.